These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38906766)

  • 1. Mesangial and endocapilar proliferative glomerulonephritis and scabies infection: A causal or circumstantial relationship?
    González Martínez MÁ; Ramírez Gómez M; García Chumillas V
    Nefrologia (Engl Ed); 2024; 44(3):446-447. PubMed ID: 38906766
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of thrombin in mesangial proliferative glomerulonephritis.
    Kitamoto Y; Imamura T; Fukui H; Tomita K
    Kidney Int; 1998 Nov; 54(5):1767-8. PubMed ID: 9844159
    [No Abstract]   [Full Text] [Related]  

  • 3. Glomerulopathy in a patient with sarcocystis infestation.
    Balakrishna JP; Chacko G; Manipadam MT;
    Indian J Pathol Microbiol; 2013; 56(3):285-7. PubMed ID: 24152512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Mediterranean fever and mesangial proliferative glomerulonephritis: report of a case and review of the literature.
    Cagdas DN; Gucer S; Kale G; Duzova A; Ozen S
    Pediatr Nephrol; 2005 Sep; 20(9):1352-4. PubMed ID: 15971069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesangial proliferative glomerulonephritis in a patient with hepatic hydatid cysts: a case report in an African male.
    Okelo GB
    Trans R Soc Trop Med Hyg; 1988; 82(3):452. PubMed ID: 3232184
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis.
    Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T
    J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman's disease by an anti-interleukin-6 receptor antibody (tocilizumab).
    Otani N; Morishita Y; Oh I; Saito O; Takemoto F; Muto S; Kusano E
    Intern Med; 2012; 51(11):1375-8. PubMed ID: 22687845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial proliferative glomerulonephritis and nephrotic syndrome with hepatitis A virus infection.
    Mathur RC; Mathur NC
    Indian Pediatr; 1996 Dec; 33(12):1051-3. PubMed ID: 9141810
    [No Abstract]   [Full Text] [Related]  

  • 9. Type III membranoproliferative glomerulonephritis in primary Sjögren's syndrome.
    Schlesinger I; Carlson TS; Nelson D
    Conn Med; 1989 Nov; 53(11):629-32. PubMed ID: 2620522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Castleman's disease and mesangial proliferative glomerulonephritis: the role of interleukin-6.
    Lui SL; Chan KW; Li FK; Cheng IK; Chan TM
    Nephron; 1998; 78(3):323-7. PubMed ID: 9546694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity.
    Alpers CE; Biava CG
    Clin Nephrol; 1989 Aug; 32(2):68-74. PubMed ID: 2766585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features in patients with isolated C3 mesangial proliferative glomerulonephritis.
    Manno C; Proscia AR; Laraia E; Giangrande M; Di Carlo M; Salvatore C; Tasco A; Schena FP
    Nephrol Dial Transplant; 1990; 5 Suppl 1():78-80. PubMed ID: 2129468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranoproliferative glomerulonephritis in Takayasu's arteritis.
    Yoshikawa Y; Truong LD; Mattioli CA; Lederer E
    Am J Nephrol; 1988; 8(3):240-4. PubMed ID: 2907268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of mesangial proliferative glomerulonephritis with endothelial damage].
    Miki Y; Shimizu H; Danbara A; Fujita Y; Ito Y; Matsuo S
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):547-51. PubMed ID: 12476592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesangial proliferative glomerulonephritis triggered by spleno-renal shunt in a cirrhotic patient.
    Rana SS; Das K; Mukhopadhyay S; Dinda AK; Kar P
    J Assoc Physicians India; 2002 Feb; 50():266-7. PubMed ID: 12038661
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis.
    Horii Y; Iwano M; Hirata E; Shiiki M; Fujii Y; Dohi K; Ishikawa H
    Kidney Int Suppl; 1993 Jan; 39():S71-5. PubMed ID: 8468929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhotic glomerulonephritis: an underdiagnosed condition.
    Ori Y; Korzets A; Sandbank J; Lurie B; Zeidman A; Gafter U
    Isr J Med Sci; 1996 Dec; 32(12):1222-4. PubMed ID: 9007158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of exercise loading for a long period on the renal function of the children with mesangial proliferative glomerulonephritis].
    Furuse A; Ushijima T; Terashima T; Karashima S; Hattori S; Matsuda I
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1081-7. PubMed ID: 1808359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerulonephritis in autopsy cases with hepatitis C virus infection.
    Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kobayashi M; Kobayashi M; Kumada H
    Intern Med; 1998 Oct; 37(10):836-40. PubMed ID: 9840704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy.
    Markowitz GS; Cheng JT; Colvin RB; Trebbin WM; D'Agati VD
    J Am Soc Nephrol; 1998 Dec; 9(12):2244-52. PubMed ID: 9848778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.